23761-23-1Relevant articles and documents
Preparation method 3 - oxocyclobutane-based carboxylic acid
-
Paragraph 0033-0035, (2021/10/27)
The invention discloses a preparation method of 3 -oxocyclobutane-based carboxylic acid, and belongs to the technical field of synthesis of medical intermediates. The ketone is protected from 1, 3 -dihydroxyacetone by condensation with trimethyl orthoformate to give 2, 2 -dimethoxy -1, 3 -propanediol, followed by reaction with malonate to give 3, 3 -dimethylcyclobutyl -1, 1 -dicarboxylic acid diester, followed by hydrolysis under acidic conditions. Decarboxylation and deprotection to yield 3 -oxocyclobutane-based carboxylic acids. The method has the advantages of high yield, common and easily available raw materials, simple flow and industrial amplification prospect.
Preparation method of 3-(benzyloxy)-1-cyclobutanone
-
Paragraph 0046-0048, (2020/07/12)
The invention relates to the technical field of organic synthesis, and specifically relates to synthesis of a medical intermediate 3-(benzyloxy)-1-cyclobutanone, according to the invention, 3-dibromo-2,3-dibromo-2,3,3-tetramethylpiperidine and diisopropyl malonate are used as initial raw materials; firstly, cyclobutane (I) is obtained through a nucleophilic substitution reaction; deprotection andhydrolysis are carried out on a compound (I) under the action of an acid to obtain 3-oxocyclobutanecarboxylic acid (II), the compound (II) is converted into a carboxylic acid silver salt, a Hunsdiecker reaction is carried out on the carboxylic acid silver salt and elemental bromine to obtain alkyl bromide (III), and a nucleophilic substitution reaction is performed on the compound (III) and benzylalcohol to obtain 3-(benzyloxy)-1-cyclobutanone (IV). The method provides a simple industrial production route for 3-(benzyloxy)-1-cyclobutanone, and has the advantages of simple reaction operation,mild reaction conditions and low cost.
Preparation method of 3-oxocyclobutylcarboxylic acid
-
Paragraph 0028-0084, (2019/01/24)
The invention belongs to the technical field of organic synthesis, and specifically relates to a preparation method of 3-oxocyclobutylcarboxylic acid. According to the preparation method, 3,3-dimethoxylcyclobutyl-1,1-diisopropyl dicarboxylate, methanol, and sodium hydroxide are taken as the raw materials, and raw materials react with hydrochloric acid to prepare 3-oxocyclobutylcarboxylic acid. Thereactions are quick, the method is simple, the technology is safe, the raw materials are easily available and cheap, the yield of the two-step reactions can reach 80% or more, and the production purity and yield are effectively increased.
Preparation method of 3-oxo-cyclobutanecarboxylic acid
-
Paragraph 0010; 0011; 0012; 0013, (2017/07/22)
The invention relates to a preparation method of 3-oxo-cyclobutanecarboxylic acid. The preparation method comprises the following steps: enabling 3,3-dimethoxy cyclobutane-1,1-diisopropyl dicarboxylate to react for 4h in a certain concentration of strong alkaline solution at the room temperature; then, adding a certain volume of concentrated hydrochloric acid, continuously carrying out a reflux reaction for 24-48h, and finishing the reaction; cooling the product to the room temperature, extracting by using ethyl acetate, carrying out spin drying, and carrying out recrystallization on the obtained crude product to obtain the pure product. The preparation method is easier in reaction raw material obtaining and rapid in reaction; ethyl ether is not used in the aftertreatment, so that the operation is safe; furthermore, the product is good in yield and high in purity.
ANTIBACTERIAL AGENTS
-
Page/Page column 105, (2014/10/18)
Antibacterial compounds of formula (I) are provided, as well as stereoisomers and pharmaceutically acceptable salts and esters thereof; pharmaceutical compositions comprising such compounds; methods of treating bacterial infections by the administration of such compounds; and processes for the preparation of such compounds.
CYCLIC AMINE SUBSTITUTED OXAZOLIDINONE CETP INHIBITOR
-
, (2012/05/19)
CCompounds having the structure of Formula I, including pharmaceutically acceptable salts of the compounds, are CETP inhibitors and are useful for raising HDL-cholesterol, reducing LDL-cholesterol, and for treating or preventing atherosclerosis. In the compound of Formula I, A3 is a substitiuted phenyl group or indanyl group.Formula (I)
Elucidating the Origin of diastereoselectivity in a self-replicating system: Selfishness versus altruism
Dieckmann, Arne,Beniken, Sabrina,Lorenz, Christian D.,Doltsinis, Nikos L.,Von Kiedrowski, Guenter
supporting information; experimental part, p. 468 - 480 (2011/03/18)
We have investigated a diastereoselective self-replicating system based on a cycloaddition of a fulvene derivative and a maleimide using a two-pronged approach of combining NMR spectroscopy with computational modelling. Two diastereomers are formed with identical rates in the absence of replication. When replication is enabled, one diastereomer takes over the resources as a "selfish" autocatalyst, while exploiting the competitor as a weak "altruist", resulting in a diastereoselectivity of 16:1. We applied 1D and 2D NMR spectroscopic techniques supported by ab initio chemical shifts as well as ab initio molecular dynamics simulations to study the structure and dynamics of the underlying network. This powerful combination allowed us to decipher the energetic and structural rationale behind the observed behaviour, while static computational methods currently used in the field did not.
Trifluoromethyl-substituted analogues of 1-aminocyclobutane-1-carboxylic acid
Radchenko, Dmytro S.,Mykhailiuk, Pavel K.,Bezdudny, Andrii V.,Komarova, Igor V.
scheme or table, p. 1827 - 1829 (2009/12/04)
Trifluoromethyl-substituted analogues of the 1-amino-cyclobutane-1- carboxylic acid - 1-amino-3-(trifluoromethyl) cyclobutanecarboxylic and 1-amino-3,3-bis(trifluoromethyl)cyclobutane-carboxylic acids - have been synthesized from 1,3-dibromoacetone dimethyl ketal. The key step of the syntheses is a transformation of the acid moiety into the trifluoromethyl group using SF4 and HF. Georg Thieme Verlag Stuttgart.
AZETIDINE AND CYCLOBUTANE DERIVATIVES AS JAK INHIBITORS
-
Page/Page column 46, (2009/09/28)
The present invention relates to azetidine and cyclobutane derivatives, as well as their compositions, methods of use, and processes for preparation, which are JAK inhibitors useful in the treatment of JAK-associated diseases including, for example, inflammatory and autoimmune disorders, as well as cancer.
AMINO ACID COMPOUNDS
-
Page/Page column 44, (2009/12/23)
[Problem] To provide novel compounds that are S1P1 receptor agonists and exhibit an immunosuppressive activities by inducing lymphocyte sequestration in secondary lymphoid tissues. In addition, to provide a pharmaceutical agent which comprises the compounds as an effective component, in particular to provide a therapeutic and/or prophylactic agent for an autoimmune disease and the like. [Solving Means] Amino acid compounds that are represented by the following Formula (1) are provided